Kedrion Notes 2019 Tender Offer results
Kedrion has accepted for purchase Notes validly tendered for a total aggregate principal amount equal to €150,716,000
Cash Tender Offer for Notes due 24 April 2019
Kedrion S.p.A. announced Cash Tender Offer for its €300,000,000 4.625 per cent. outstanding Notes due 24 April 2019
KEDPlasma welcomes donors to its new Augsburg collection center
Plasma collected in Germany is essential to Kedrion Biopharma’s plasma-derived therapies
Humanitarian programme to reduce the gap in the access to clotting factors
Kedrion helps the WISH project come true: Italian CNS and the World Federation of Hemophilia sign agreement in London
Kedrion SpA’s Shareholders approve 2014 financial statement
A 466 million euros’ turnover with a 9,8% rise on 2013
Kedrion unveils its new manufacturing plant in Castelvecchio Pascoli
The company has invested over 67 million euros and is expected to create between 70 and 90 new jobs
Kedrion CEO took part in “Italy meets the USA” summit on February 10, 2015
The NY meeting was aimed at highlighting significant investment opportunities in Italy
Kedrion receives the “VedoGreen, Green Excellence in Innovation” Award
The awards ceremony held in Milan on November 17, during Waiting for Expo 2015, Green Economy 2.0
Kedrion joins the programme “ELITE for Large Corporates”
Launched by Borsa Italiana, ELITE is targeted to companies aiming at strengthening their global leadership
Kedrion announces more factual, long-term role in Africa
The company’s efforts try to grant African patients better access to treatments
